Every SEC Form 3/4/5 on record for this filer (CIK 1763923) — 1 issuer, 21 transactions. Section-16 filings only: what they filed, not a biography, and titles are as filed on their latest form at each issuer.
| Ticker | Company | Role as filed | On file | Forms | Open-market net |
|---|---|---|---|---|---|
| PTGX | Protagonist Therapeutics, Inc | Chief Development Officer | 2019-01-09 → 2024-11-27 | 16 | −$6M |
| Ticker | Date | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| PTGX | 2024-11-26 | Sell | 19,191 | $45.50 | $873,191 | 266,983 |
| PTGX | 2024-11-25 | Sell | 103,437 | $46.04 | $5M | 256,174 |
| PTGX | 2024-01-09 | Sell | 5,000 | $25.00 | $125,000 | 187,567 |
1 of 1 issuers are covered and open a security page; the rest are on file here only.